Awareness of opioid risks, policies is important for NPs

06/21/2013 | ClinicalAdvisor.com

Familiarity with the FDA's risk evaluation and mitigation strategies for extended-release and long-acting opioids is important even for nurse practitioners who do not prescribe those drugs, experts said at the AANP National Conference in Las Vegas. "You may not be prescribing opioids to your patients, but another health care provider may be, or they could be getting them from another patient. Friends and family are the biggest source of opioid pain pills, either as gifts or through theft," nurse practitioner and pain management specialist Deborah Kiley said.

View Full Article in:

ClinicalAdvisor.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC